Literature DB >> 1793647

Incidence of toxoplasmosis in patients with glandular fever and in healthy blood donors.

J D Johnson1, R E Holliman.   

Abstract

The differential diagnosis of the clinical syndrome of glandular fever may include Epstein-Barr virus, cytomegalovirus and Toxoplasma gondii infection. Some general practitioners and clinical laboratories choose to perform serological investigations for toxoplasmosis in all patients with glandular fever, who have negative Paul-Bunnell test results. The validity of this approach was assessed by a comparison of the incidence of toxoplasmosis in healthy blood donors and in a group of patients with clinically diagnosed glandular fever who had negative Paul-Bunnell tests. The results showed no significant difference in the frequency of acute or chronic toxoplasma infection between the two groups. In view of these findings, together with evidence of the lack of appropriate effective therapy for toxoplasmosis in immunocompetent individuals, and the dangers of failing to recognize concurrent severe disease of a separate aetiology, we recommend that Paul-Bunnell negative patients with clinically diagnosed glandular fever are not investigated for toxoplasmosis as a routine. However, these guidelines do not apply to patients at risk of severe sequelae from toxoplasma infection, notably pregnant women, who still require a full assessment.

Entities:  

Mesh:

Year:  1991        PMID: 1793647      PMCID: PMC1371719     

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN: 0960-1643            Impact factor:   5.386


  10 in total

1.  Toxoplasmosis and infectious mononucleosis.

Authors:  J S REMINGTON; C G BARNETT; M MEIKEL; M N LUNDE
Journal:  Arch Intern Med       Date:  1962-11

2.  Glandular toxoplasmosis; a survey of 30 cases.

Authors:  J K BEVERLEY; C P BEATTIE
Journal:  Lancet       Date:  1958-08-23       Impact factor: 79.321

3.  Direct agglutination test and other assays for measuring antibodies to Toxoplasma gondii.

Authors:  J Johnson; K Duffy; L New; R E Holliman; B S Chessum; D G Fleck
Journal:  J Clin Pathol       Date:  1989-05       Impact factor: 3.411

Review 4.  Clinical spectrum in 107 cases of toxoplasmic lymphadenopathy.

Authors:  R E McCabe; R G Brooks; R F Dorfman; J S Remington
Journal:  Rev Infect Dis       Date:  1987 Jul-Aug

5.  Assessment of immunoglobulin-M immunosorbent agglutination assay (ISAGA) for detecting toxoplasma specific IgM.

Authors:  K T Duffy; P J Wharton; J D Johnson; L New; R E Holliman
Journal:  J Clin Pathol       Date:  1989-12       Impact factor: 3.411

6.  Clinical and laboratory findings in the Paul-Bunnell negative glandular fever-fatigue syndrome.

Authors:  R Read; E Larson; J Harvey; A Edwards; B Thomson; M Briggs; J Fox
Journal:  J Infect       Date:  1990-09       Impact factor: 6.072

7.  Toxoplasmosis and systemic lupus erythematosus.

Authors:  M H Wilcox; R J Powell; S F Pugh; A H Balfour
Journal:  Ann Rheum Dis       Date:  1990-04       Impact factor: 19.103

8.  Toxoplasmosis, an innocuous disease?

Authors:  C C Baker; C P Farthing; P Ratnesar
Journal:  J Infect       Date:  1984-01       Impact factor: 6.072

9.  Discrepant toxoplasma latex agglutination test results.

Authors:  R E Holliman; J Johnson; K Duffy; L New
Journal:  J Clin Pathol       Date:  1989-02       Impact factor: 3.411

10.  Age-sex distribution of various diseases with particular reference to toxoplasmic lymphadenopathy.

Authors:  J K Beverley; D G Fleck; W Kwantes; G B Ludlam
Journal:  J Hyg (Lond)       Date:  1976-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.